Posted On: 05/21/2014 3:21:53 PM
Post# of 5949
OTC Market Update From Angel - 2/21/2014, 1:35PM
Angel Stanz (BG Medical)
To Me
Today at 1:35 PM
BN,
I spoke with OTC Markets today. Once again, the "only one breadcrumb at a time" approach from them prevails. While they stated the stock would be upgraded to OTC Limited status tomorrow, the Caveat Emptor status would also remain until additional paperwork was provided. Thus, skull and crossbones remain, despite our ongoing compliance.
The additional paperwork is in progress. This will take about a week, considering if all parties in the equation react promptly. Once completed and submitted, OTC Markets will evaluate this upon their 3 to 5 day review schedule, at which point they may or may not issue another "breadcrumb" for further changes. This pattern has been occurring for quite some time.
We remain diligent (albeit as frustrated as company shareholders) in resolving this matter.
Warm Regards,
Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
************@bgmedtech.com
(855) 723-3283
Angel Stanz (BG Medical)
To Me
Today at 1:35 PM
BN,
I spoke with OTC Markets today. Once again, the "only one breadcrumb at a time" approach from them prevails. While they stated the stock would be upgraded to OTC Limited status tomorrow, the Caveat Emptor status would also remain until additional paperwork was provided. Thus, skull and crossbones remain, despite our ongoing compliance.
The additional paperwork is in progress. This will take about a week, considering if all parties in the equation react promptly. Once completed and submitted, OTC Markets will evaluate this upon their 3 to 5 day review schedule, at which point they may or may not issue another "breadcrumb" for further changes. This pattern has been occurring for quite some time.
We remain diligent (albeit as frustrated as company shareholders) in resolving this matter.
Warm Regards,
Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
************@bgmedtech.com
(855) 723-3283
(0)
(0)
